TLX logo

TLXTelix Pharmaceuticals Limited American Depositary Shares

$9.30
$0.24
(2.52%)
Today
Closed $9.30
$0.00
(0.00%)
After Hours
Updated: 06:35 PM EDT
EarningsAug 19
Mkt Cap$3.16B
Vol262,829.00
News
all
press releases
Telix Pharmaceuticals Limited (NASDAQ:TLX) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine research firms that are presently covering the stock...
MarketBeat
News Placeholder
More News
News Placeholder
Telix Pharmaceuticals Webinar Highlights Next-Gen PSMA Therapy, OPTIMAL-PSMA Enrollment Nears End
Telix Pharmaceuticals (NASDAQ:TLX) hosted an educational webinar outlining its next-generation prostate-specific membrane antigen (PSMA) radiopharmaceutical strategy, with management and a clinical...
MarketBeat
News Placeholder
Regeneron Boosts Cancer Pipeline Through Telix Collaboration
Regeneron teams up with Telix in a 50/50 radiopharma deal, betting on next-gen cancer therapies to expand its oncology pipeline and long-term growth.
Zacks
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - What's Next?
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - Time to Sell...
MarketBeat
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Should You Buy?
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Here's Why...
MarketBeat
News Placeholder
Wedbush Reaffirms Outperform Rating for Telix Pharmaceuticals (NASDAQ:TLX)
Wedbush reissued an "outperform" rating and set a $22.00 price target on shares of Telix Pharmaceuticals in a report on Monday...
MarketBeat
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Given "Buy" Rating at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Telix Pharmaceuticals in a research report on Monday...
MarketBeat
News Placeholder
Regeneron Pharma Partners Telix Pharma To Jointly Develop Radiopharmaceutical Therapies
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Telix Pharmaceuticals Ltd. (TLX, TLX.AX) announced Monday a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies...
Nasdaq News: Markets
News Placeholder
Telix And Regeneron Partner To Advance Next-Generation Radiopharmaceutical Therapies
(RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) and Regeneron Pharmaceuticals, Inc. (REGN) have announced a collaboration to jointly develop and commercialize next-generation...
Nasdaq News: Markets
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised Telix Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.